Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice

Molecular Psychiatry

Volumn 9, Issue 4, 2004, Pages 417-425

  Frankland, P W ^a,b,c   Wang, Y ^a,b   Rosner, B ^b   Shimizu, T ^a,b   Balleine, B W ^b   Dykens, E M ^b   Ornitz, E M ^b   Silva, A J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

FMRP; Mouse model; Prepulse inhibition; Startle

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ADAPTIVE BEHAVIOR; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INTELLIGENCE QUOTIENT; KNOCKOUT MOUSE; LEARNING; LEARNING DISORDER; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PREDICTION; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; RODENT; SCHOOL CHILD; SENSORIMOTOR FUNCTION; SENSORIMOTOR NEUROPATHY; SPECIES DIFFERENCE;

ACOUSTIC STIMULATION; ADOLESCENT; ANALYSIS OF VARIANCE; ANIMALS; CHILD; CHILD BEHAVIOR DISORDERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; ION CHANNEL GATING; MALE; MENTAL DISORDERS; MICE; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; RNA-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX; STARTLE REACTION;

EID: 2042473496     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001432     Document Type: Article

References (41)

1. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile x syndrome. Am J Med Genet 1996; 64: 196-197.
2. Verkerk AJ et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905-914.
3. Hagerman RJ, Hagerman PJ. Fragile X Syndrome: Diagnosis, Treatmen, and Research, Vol xii Johns Hopkins University Press: Baltimore, 2002 540pp.
4. Kooy RF, Willemsen R, Oostra BA. Fragile X syndrome at the turn of the century. Mol Med Today 2000; 6: 193-198.
5. O'Donnell WT, Warren ST. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 2002; 25: 315-338.
6. Greenough WT et al. Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci (USA) 2001; 98: 7101-7106.
7. Bakker CE et al. Fmr1 knockout mice - a model to study fragile X mental retardation. Cell 1994; 78: 23-33.
8. Peier AM et al. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet 2000; 9: 1145-1159.
9. Nielsen DM, Derber WJ, McClellan DA, Crnic LS. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 2002; 927: 8-17.
10. Miller LJ et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 1999; 83: 268-279.
11. Geyer MA, McIlwain KL, Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 2002; 7: 1039-1053.
12. Sparrow SS, Balla D, Cicchetti DV. Vineland Adaptive Behavior Scales. American Guidance Service: Circle Pines, MN, 1984.
13. Achenbach TM. Manual of the Child Behavior Checklist. University of Vermont: Burlington, VT, 1991.
14. Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: diagnostic validity. Br J Psychiatry 1999; 175: 444-451.
15. Kaufman AS, Kaufman NL. Kaufman Brief Intelligence Test. American Guidance Service: Circle Pines, MN, 1990.
16. Ornitz EM et al. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry 1999; 45: 1455-1466.
17. Carvalho OM, Silva AJ, Balleine BW. Evidence of selective learning deficits on tests of Pavlovian and instrumental conditioning on alpha-CaMKII-T286 mutant mice. Int J Comp Psychol 2001; 14: 161-174.
18. Dickinson A, Squire S, Varga Z, Smith JW. Omission learning after instrumental pretraining. Quart J Exp Psychol Comp Physiol Psychol 1998; 51B: 271-286.
19. Hutchison KE, Swift R, Effect of D-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology (Berl) 1999; 143: 394-400.
20. Swerdlow NR et al. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology (Berl) 2002; 161: 189-201.
21. Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. J Psychopharmacol 1998; 12: 239-245.
22. Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J Psychopharmacol 2001; 15: 237-242.
23. Schachinger H, Muller BU, Strobel W, Langewitz W, Ritz R. Midazolam effects on prepulse inhibition of the acoustic blink reflex. Br J Clin Pharmacol 1999; 47: 421-426.
24. Mackeprang T, Kristiansen KT, Glenthoj BY. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol Psychiatry 2002; 52: 863-873.
25. Graham SJ, Langley RW, Bradshaw CM, Szabadi E. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J Psychopharmacol 2001; 15: 243-250.
26. Pouretemad HR, Thompson PJ, Fenwick PB. Sensorimotor gating in patients with non-epileptic seizures. Epilepsy Res 1998; 31: 1-12.
27. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001; 156: 117-154.
28. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001; 156: 234-258.
29. Chen L, Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 2001; 103: 1043-1050.
30. Van Dam D et al. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res 2000; 117: 127-136.
31. Dobkin C et al. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 2000; 100: 423-429.
32. Qin M, Kang J, Smith CB. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci (USA) 2002; 99: 15758-15763.
33. D'Hooge R et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 1997; 76: 367-376.
34. Fisch GS, Hao HK, Bakker C, Oostra BA. Learning and memory in the FMR1 knockout mouse. Am J Med Genet 1999; 84: 277-282.
35. Squire LR, Knowlton B, Musen G. The structure and organization of memory. Annu Rev Psychol 1993; 44: 453-495.
36. Balleine BW, Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology 1998; 37: 407-419.
37. Watase K, Zoghbi HY. Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 2003; 4: 296-307.
38. Jin P, Warren ST. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 2003; 28: 152-158.
39. Feng Y et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1997; 1: 109-118.
40. Tamanini F et al. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet 1997; 6: 1315-1322.
41. Bontekoe CJ et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet 2002; 11: 487-498.